The EMA’s AI Observatory 2025 report

Many activities are underway to fully exploit AI’s potential within regulatory processes, both at the EU and international levels. The latest report by the European Medicines Agency discusses advances in policy and guideline development, new AI applications, and collaborations with industry and other regulators to identify emerging opportunities and develop a common approach.

"E.I.P.G. is a European association representing the national, professional organizations of pharmacists
employed in the pharmaceutical or allied industries of the Member States of the European Union,
the European Economic Area, or European countries having a mutual recognition agreement
with the European Union on compliance control of regulated medicines."

Read More

Presentations

Our media library contains an extensive collection of presentations by EIPG Bureau members or delegates, and presentations made at Scientific Symposia.
Read More
Read More

Position Papers

EIPG issues comments and feedback in response to consultation documents and white papers released by the European Medicines Agency and the European Commission.
Read More
Read More

Education

EIPG’s initiatives dedicated to industrial pharmacist education, including the EU-funded projects MOGLYNET, PHAR-IN and PHARMINE.
Read More
Read More

Members’ Area

Member organisations can sign in here to get even more information regarding EIPG’s projects and works.
Read More

Environmental Sustainability Position Paper

The EIPG Environmental Sustainability Position Paper, approved at the 60th General Assembly in Lisbon, confirms EIPG’s commitment to a more sustainable and resilient pharmaceutical sector. The paper highlights the key role of industrial pharmacists in reducing environmental impact across operations and supply chains, while safeguarding innovation, patient safety and regulatory compliance.
Read More

The current status of digital health technologies in the EU

A report published by the DG CONNECT of the European Commission provides an in-depth analysis of the current state of the EU market for digital health technologies. These frontier innovations are largely based on AI applications and aim to provide new tools to improve the efficiency of healthcare systems and the decentralised provision of care. Many barriers are still present, with the EU lagging far behind the US in terms of the number of vendors with headquarters in its territory
Read More